Paper of the month: Biomarkers for neoadjuvant PD(L)1 therapy3 years ago

24:52

The STAMPEDE trial3 years ago

28:00

Episode 239: The STAMPEDE trial3 years ago

136:08

Episode 240: Preview of GU Cancer at ASCO 20232 years ago

27:01

Statistics for clinical trials2 years ago

38:10

ASCO23 THOR study - erdafitinib vs chemo in bladder cancer2 years ago

26:28

ASCO 2023: TALAPRO-2: Phase 3 Study of Talazoparib + Enzalutamide2 years ago

16:16

ASCO23 - PEACE-1 in CRPC2 years ago

24:55

ASCO23 - CONTACT-03 cabozantinib +/- atezolizumab in renal cancer2 years ago

27:46

ASCO23: EV pembro and erdafitinib cetrelimab in 1st line UC2 years ago

24:27